COVID-19 and end stage renal disease treatment modalities in the United States
<p>From the establishment of nearly universal health coverage for end stage renal disease in 1972 to 2021, the primary treatment modality has been in-center hemodialysis despite significant advances in home therapies such as peritoneal dialysis and home hemodialysis. </p>
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
Archives of Renal Diseases and Management - Peertechz Publications,
2021-09-28.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | peertech__10_17352_2455-5495_000036 | ||
042 | |a dc | ||
100 | 1 | 0 | |a John D Sullivan |e author |
245 | 0 | 0 | |a COVID-19 and end stage renal disease treatment modalities in the United States |
260 | |b Archives of Renal Diseases and Management - Peertechz Publications, |c 2021-09-28. | ||
520 | |a <p>From the establishment of nearly universal health coverage for end stage renal disease in 1972 to 2021, the primary treatment modality has been in-center hemodialysis despite significant advances in home therapies such as peritoneal dialysis and home hemodialysis. </p> | ||
540 | |a Copyright © John D Sullivan et al. | ||
546 | |a en | ||
655 | 7 | |a Commentary |2 local | |
856 | 4 | 1 | |u https://doi.org/10.17352/2455-5495.000036 |z Connect to this object online. |